Literature DB >> 3554885

Incorporation of nonviable bone grafts. Autoclaved autogeneic and frozen allogeneic bone grafts compared in the rabbit.

P Köhler, J E Glas, S Larsson, A Kreicbergs.   

Abstract

In 14 adult rabbits the middle third of the ulna was resected bilaterally followed by reimplantation of resected bone after autoclaving on one side and transplantation of allogeneic bone on the other. In 7 animals the bilateral implants were supplemented with allogeneic bone matrix. The reconstructions were studied in vivo by serial radiography, scintigraphy, and bone mineral determination. The animals were killed at 16 weeks, and the ulnar reconstructions further studied by high resolution radiography, 45Ca autoradiography, and histology. In both types of nonsupplemented reconstructions, new bone formation was poor; nonunion occurred in three out of seven autoclaved reimplants and in five out of seven allogeneic transplants. Supplemented with allogeneic bone matrix, both types of reconstructions exhibited abundant new bone formation and complete incorporation of all implants. Enhancement of new bone formation is probably more important than the type of nonviable bone graft chosen for reconstruction of large skeletal defects.

Entities:  

Mesh:

Year:  1987        PMID: 3554885     DOI: 10.3109/17453678709146343

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  3 in total

1.  Gamma Radiation Sterilization Reduces the High-cycle Fatigue Life of Allograft Bone.

Authors:  Anowarul Islam; Katherine Chapin; Emily Moore; Joel Ford; Clare Rimnac; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2015-10-13       Impact factor: 4.176

2.  Bone transplantation.

Authors:  L Schweiberer; H Stützle; H K Mandelkow
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

3.  Moderate heat treatment of bone allografts. Experimental results of osteointegration.

Authors:  J H Kühne; R Bartl; C Hammer; H J Refior; V Jansson; M Zimmer
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.